China Ovarian Cancer BRCA Testing Study - CRONUS

Study identifier:D133FR00117

ClinicalTrials.gov identifier:NCT03203993

EudraCT identifier:N/A

CTIS identifier:N/A

Terminated/Withdrawn

Official Title

China local BRCA testing and exploration of ovarian cancer treatment outcomes of different BRCA status in newly diagnosed epithelial ovarian cancer patients

Medical condition

ovarian cancer

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

Female

Actual Enrollment

29

Study type

Observational

Age

18 Years - 130 Years

Date

Study Start Date: 31 Jan 2018
Primary Completion Date: 31 Mar 2020
Study Completion Date: 31 Mar 2020

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: -

Verification:

Verified 01 Oct 2020 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria